Repaglinide 1 mg + Voglibose 0.3 mg Tablet | PCD Pharma Manufacturer & Supplier India | Trumac Healthcare



Repaglinide 1 mg + Voglibose 0.3 mg Tablet — manufactured by Trumac Healthcare

Repaglinide 1 mg + Voglibose 0.3 mg Tablet

WHO-GMP Manufacturer & PCD Pharma Franchise Supplier in India

Salt: Repaglinide 1 mg + Voglibose 0.3 mg
Form: Tablet
Class: Meglitinide + biguanide / alpha-glucosidase inhibitor
✓ WHO-GMP
✓ Pan-India Monopoly PCD
✓ 1 Brand Options

Pricing, brochure & monopoly territory within 24 hrs.

Our Repaglinide 1 mg + Voglibose 0.3 mg Tablet Brand Options (1 option)

Trumac Healthcare manufactures and supplies the following Repaglinide 1 mg + Voglibose 0.3 mg Tablet brands for PCD pharma distribution. Click any brand to view full specifications and packaging.

Reparon-V 1/0.3 Tablet

Reparon-V 1/0.3 Tablet

Pack: 10 x 10 (Alu-Alu)

MRP: ₹1990

View Reparon-V 1/0.3 Tablet →

Repaglinide 1 mg + Voglibose 0.3 mg Tablet is manufactured under WHO-GMP-certified conditions by Trumac Healthcare and supplied for PCD/Propaganda-cum-Distribution pharma franchise on monopoly basis across India. Whether you are a PCD distributor, stockist or retail chemist, our Repaglinide 1 mg + Voglibose 0.3 mg formulation comes with full quality assurance, regulatory documentation and reliable pan-India despatch.

Therapeutic Indications
  • Type-2 diabetes with post-prandial hyperglycaemia
  • Patients with irregular meal patterns
  • Elderly type-2 diabetics needing flexible glucose control
Mechanism of Action

Repaglinide is a meglitinide insulin secretagogue. It closes pancreatic beta-cell ATP-sensitive K+ channels (binding a different site than sulphonylureas), depolarising the cell and triggering insulin secretion. Short half-life produces a rapid, post-prandial insulin spike — useful for control of postprandial hyperglycaemia. Voglibose delays intestinal carbohydrate digestion, complementing Repaglinide's post-prandial insulin spike.

Dosage & Administration
  • Adults: take 15–30 minutes before each main meal
  • Skip dose if skipping meal
  • Titrate based on glycaemic response
  • Use under physician supervision
Side Effects
  • Hypoglycaemia (less than long-acting sulphonylureas)
  • Weight gain (mild)
  • GI upset
Contraindications
  • Type-1 diabetes
  • Diabetic ketoacidosis
  • Severe hepatic impairment
  • Pregnancy and breastfeeding
Storage

Store below 25°C.

PCD Pharma Franchise for Repaglinide 1 mg + Voglibose 0.3 mg Tablet

  • ✓ WHO-GMP certified manufacturing facility
  • ✓ Pan-India monopoly distribution rights available
  • ✓ Multiple pack sizes: 10 x 10 (Alu-Alu)
  • ✓ Trade-friendly PTR / PTS margins
  • ✓ Free promotional material on request
  • ✓ Full DCGI documentation and quality certificates supplied

Trumac Healthcare offers 1 brand option for Repaglinide 1 mg + Voglibose 0.3 mg Tablet — each available in different pack sizes with trade-friendly margins. View the brand-specific pages below for detailed specifications, MRPs and packaging options.

For PCD franchise opportunities, monopoly distribution rights, or third-party contract manufacturing of Repaglinide 1 mg + Voglibose 0.3 mg Tablet, contact our business development team. WhatsApp +91 9041677932 or email info@trumachealthcare.net.

Frequently Asked Questions

Who is the manufacturer of Repaglinide 1 mg + Voglibose 0.3 mg Tablet?

Trumac Healthcare is a WHO-GMP certified manufacturer of Repaglinide 1 mg + Voglibose 0.3 mg Tablet in India. We supply our own brand range (see brand options above) and also offer third-party contract manufacturing for PCD distributors.

Is Repaglinide 1 mg + Voglibose 0.3 mg Tablet available for PCD pharma franchise on monopoly basis?

Yes. We offer Repaglinide 1 mg + Voglibose 0.3 mg Tablet for PCD/Propaganda-cum-Distribution pharma franchise on monopoly basis across all districts of India. Contact our business development team for pricing and territory availability.

What pack sizes are available for Repaglinide 1 mg + Voglibose 0.3 mg Tablet?

Available pack sizes include: 10 x 10 (Alu-Alu).

What is the MRP / trade price for Repaglinide 1 mg + Voglibose 0.3 mg Tablet?

MRPs range from ₹1990 to ₹1990 across our brand variants. Trade-friendly PTR/PTS margins available on request — WhatsApp +91 9041677932 for current rates.

How do I place an order or franchise enquiry?

WhatsApp +91 9041677932 or email info@trumachealthcare.net with your enquiry. Our team will revert within 24 hours with full pricing, brochure and franchise terms.

Ready to start your PCD franchise for Repaglinide 1 mg + Voglibose 0.3 mg Tablet?

Get Pricing & Franchise Terms →